Delivery Order SPE2DB22D1202-SPE2DB25FVFA7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $4,167.89 for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a $4,165.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery under a non-competitive set-aside arrangement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999.999 billion...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $6,078.90 to provide Repatha 140 mg/ml SureClick Autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for the company to supply a range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency has awarded a delivery order valued at $4,865.38 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,033.64 contract is for the provision of Repatha 140 mg/mL SureClick injectable medication. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
- This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) covers the delivery of Repatha 140 mg/ml SureClick autoinjector medication. The $2,033.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick autoinjectors to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order valued at $5,761.28. The contract has an ultimate completion date of May 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a $1,184.33 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 140 mg/mL Repatha SureClick autoinjectors, a specialty medication used to treat cardiovascular conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award, valued at $1,016.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Repatha 140 mg/ml SureClick autoinjectors, a specialty medication used to treat cardiovascular conditions. The contract is a firm-fixed-price delivery order with a period of performance through November 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFA7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, valued at $12,915.41. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a pediatric delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million and running through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement across the Department of Defense and Veterans Health Administration. The company's substantial IDC with DLA enables the supply of a diverse range of pharmaceuticals, medical devices, and healthcare commodities to support military healthcare operations worldwide. This specific delivery order for Repatha, a PCSK9 inhibitor used for cholesterol management, reflects the company's role in providing specialty medications to military and federal healthcare systems. No set-aside designation was applied to this award, indicating open competition among qualified vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 7/18/25 |